Your browser doesn't support javascript.
loading
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.
Patil, Vijay; Noronha, Vanita; Dhumal, Sachin Babanrao; Joshi, Amit; Menon, Nandini; Bhattacharjee, Atanu; Kulkarni, Suyash; Ankathi, Suman Kumar; Mahajan, Abhishek; Sable, Nilesh; Nawale, Kavita; Bhelekar, Arti; Mukadam, Sadaf; Chandrasekharan, Arun; Das, Sudeep; Vallathol, Dilip; D'Souza, Hollis; Kumar, Amit; Agrawal, Amit; Khaddar, Satvik; Rathnasamy, Narmadha; Shenoy, Ramnath; Kashyap, Lakhan; Rai, Rahul Kumar; Abraham, George; Saha, Saswata; Majumdar, Swaratika; Karuvandan, Naveen; Simha, Vijai; Babu, Vasu; Elamarthi, Prahalad; Rajpurohit, Annu; Kumar, Kanteti Aditya Pavan; Srikanth, Anne; Ravind, Rahul; Banavali, Shripad; Prabhash, Kumar.
Afiliación
  • Patil V; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Noronha V; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Dhumal SB; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Joshi A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Menon N; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Bhattacharjee A; Section of Biostatistics, Centre for Cancer Epidemiology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Kulkarni S; Department of Radiodiagnosis, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Ankathi SK; Department of Radiodiagnosis, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Mahajan A; Department of Radiodiagnosis, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Sable N; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Nawale K; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Bhelekar A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Mukadam S; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Chandrasekharan A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Das S; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Vallathol D; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • D'Souza H; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Kumar A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Agrawal A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Khaddar S; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Rathnasamy N; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Shenoy R; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Kashyap L; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Rai RK; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Abraham G; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Saha S; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Majumdar S; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Karuvandan N; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Simha V; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Babu V; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Elamarthi P; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Rajpurohit A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Kumar KAP; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Srikanth A; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Ravind R; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Banavali S; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
  • Prabhash K; Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India. Electronic address: id-kumarprabhashtmh@gmail.com.
Lancet Glob Health ; 8(9): e1213-e1222, 2020 09.
Article en En | MEDLINE | ID: mdl-32827483
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cisplatino / Neoplasias de Cabeza y Cuello / Metástasis de la Neoplasia / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Guideline / Health_economic_evaluation Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Lancet Glob Health Año: 2020 Tipo del documento: Article País de afiliación: India
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cisplatino / Neoplasias de Cabeza y Cuello / Metástasis de la Neoplasia / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Guideline / Health_economic_evaluation Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Lancet Glob Health Año: 2020 Tipo del documento: Article País de afiliación: India